Cargando…

Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

OBJECTIVE: This study explores the clinical characteristics of patients with diabetes with severe covid-19, and the association of diabetes with survival duration in patients with severe covid-19. RESEARCH DESIGN AND METHODS: In this single-center, retrospective, observational study, the clinical an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yongli, Yang, Yan, Wang, Fen, Ren, Huihui, Zhang, Shujun, Shi, Xiaoli, Yu, Xuefeng, Dong, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222577/
https://www.ncbi.nlm.nih.gov/pubmed/32345579
http://dx.doi.org/10.1136/bmjdrc-2020-001343
_version_ 1783533606149292032
author Yan, Yongli
Yang, Yan
Wang, Fen
Ren, Huihui
Zhang, Shujun
Shi, Xiaoli
Yu, Xuefeng
Dong, Kun
author_facet Yan, Yongli
Yang, Yan
Wang, Fen
Ren, Huihui
Zhang, Shujun
Shi, Xiaoli
Yu, Xuefeng
Dong, Kun
author_sort Yan, Yongli
collection PubMed
description OBJECTIVE: This study explores the clinical characteristics of patients with diabetes with severe covid-19, and the association of diabetes with survival duration in patients with severe covid-19. RESEARCH DESIGN AND METHODS: In this single-center, retrospective, observational study, the clinical and laboratory characteristics of 193 patients with severe covid-19 were collected. 48 patients with severe covid-19 had diabetes, and 145 patients (ie, the controls) did not have diabetes. A severe case was defined as including at least one of the following criteria: (1) Respiratory rate >30/min. (2) Oxygen saturation ≤93%. (3) PaO(2)/FiO(2)≤300 mm Hg. (4) Patients, either with shock or respiratory failure, requiring mechanical ventilation, or combined with other organ failure, requiring admission to intensive care unit (ICU). RESULTS: Of 193 patients with severe covid-19, 48 (24.9%) had diabetes. Compared with patients with severe covid-19 without diabetes, patients with diabetes were older, susceptible to receiving mechanical ventilation and admission to ICU, and had higher mortality. In addition, patients with severe covid-19 with diabetes had higher levels of leukocyte count, neutrophil count, high-sensitivity C reaction protein, procalcitonin, ferritin, interleukin (IL) 2 receptor, IL-6, IL-8, tumor necrosis factor α, D-dimer, fibrinogen, lactic dehydrogenase and N-terminal pro-brain natriuretic peptide. Among patients with severe covid-19 with diabetes, more non-survivors were men (30 (76.9%) vs 9 (23.1%)). Non-survivors had severe inflammatory response, and cardiac, hepatic, renal and coagulation impairment. Finally, the Kaplan-Meier survival curve showed a trend towards poorer survival in patients with severe covid-19 with diabetes than patients without diabetes. The HR was 1.53 (95% CI 1.02 to 2.30; p=0.041) after adjustment for age, sex, hypertension, cardiovascular disease and cerebrovascular disease by Cox regression. The median survival durations from hospital admission in patients with severe covid-19 with and without diabetes were 10 days and 18 days, respectively. CONCLUSION: The mortality rate in patients with severe covid-19 with diabetes is considerable. Diabetes may lead to an increase in the risk of death.
format Online
Article
Text
id pubmed-7222577
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-72225772020-05-14 Clinical characteristics and outcomes of patients with severe covid-19 with diabetes Yan, Yongli Yang, Yan Wang, Fen Ren, Huihui Zhang, Shujun Shi, Xiaoli Yu, Xuefeng Dong, Kun BMJ Open Diabetes Res Care Clinical Care/Education/Nutrition OBJECTIVE: This study explores the clinical characteristics of patients with diabetes with severe covid-19, and the association of diabetes with survival duration in patients with severe covid-19. RESEARCH DESIGN AND METHODS: In this single-center, retrospective, observational study, the clinical and laboratory characteristics of 193 patients with severe covid-19 were collected. 48 patients with severe covid-19 had diabetes, and 145 patients (ie, the controls) did not have diabetes. A severe case was defined as including at least one of the following criteria: (1) Respiratory rate >30/min. (2) Oxygen saturation ≤93%. (3) PaO(2)/FiO(2)≤300 mm Hg. (4) Patients, either with shock or respiratory failure, requiring mechanical ventilation, or combined with other organ failure, requiring admission to intensive care unit (ICU). RESULTS: Of 193 patients with severe covid-19, 48 (24.9%) had diabetes. Compared with patients with severe covid-19 without diabetes, patients with diabetes were older, susceptible to receiving mechanical ventilation and admission to ICU, and had higher mortality. In addition, patients with severe covid-19 with diabetes had higher levels of leukocyte count, neutrophil count, high-sensitivity C reaction protein, procalcitonin, ferritin, interleukin (IL) 2 receptor, IL-6, IL-8, tumor necrosis factor α, D-dimer, fibrinogen, lactic dehydrogenase and N-terminal pro-brain natriuretic peptide. Among patients with severe covid-19 with diabetes, more non-survivors were men (30 (76.9%) vs 9 (23.1%)). Non-survivors had severe inflammatory response, and cardiac, hepatic, renal and coagulation impairment. Finally, the Kaplan-Meier survival curve showed a trend towards poorer survival in patients with severe covid-19 with diabetes than patients without diabetes. The HR was 1.53 (95% CI 1.02 to 2.30; p=0.041) after adjustment for age, sex, hypertension, cardiovascular disease and cerebrovascular disease by Cox regression. The median survival durations from hospital admission in patients with severe covid-19 with and without diabetes were 10 days and 18 days, respectively. CONCLUSION: The mortality rate in patients with severe covid-19 with diabetes is considerable. Diabetes may lead to an increase in the risk of death. BMJ Publishing Group 2020-04-27 /pmc/articles/PMC7222577/ /pubmed/32345579 http://dx.doi.org/10.1136/bmjdrc-2020-001343 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Clinical Care/Education/Nutrition
Yan, Yongli
Yang, Yan
Wang, Fen
Ren, Huihui
Zhang, Shujun
Shi, Xiaoli
Yu, Xuefeng
Dong, Kun
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
title Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
title_full Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
title_fullStr Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
title_full_unstemmed Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
title_short Clinical characteristics and outcomes of patients with severe covid-19 with diabetes
title_sort clinical characteristics and outcomes of patients with severe covid-19 with diabetes
topic Clinical Care/Education/Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222577/
https://www.ncbi.nlm.nih.gov/pubmed/32345579
http://dx.doi.org/10.1136/bmjdrc-2020-001343
work_keys_str_mv AT yanyongli clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes
AT yangyan clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes
AT wangfen clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes
AT renhuihui clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes
AT zhangshujun clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes
AT shixiaoli clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes
AT yuxuefeng clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes
AT dongkun clinicalcharacteristicsandoutcomesofpatientswithseverecovid19withdiabetes